ACE and Shock: They were also less likely to develop cardiogenic shock and receive digoxin and proton-pump inhibitors and were more likely to receive oral hypoglycemic agents, beta-blockers, angiotensin converting enzyme inhibitor/angiotensin II receptor blockers, dihydropyridine calcium channel blockers and statins (P<0.05).